WORLDWIDE CLINICAL TRIALS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

15/07/2010

VAT status

Active

Bankruptcy proceedings

No proceedings

WORLDWIDE CLINICAL TRIALS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Highest

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

18/06/2010

Share capital

330,000.00 PLN

Primary activity

Other professional, scientific and technical activities n.e.c. (74.90.Z - PKD 2007)

Representatives

Representatives rights

KAŻDY CZŁONEK ZARZĄDU SPÓŁKI JEST UPRAWNIONY DO SAMODZIELNEGO REPREZENTOWANIA SPÓŁKI

Representatives

Member of the management boardAndre Ganem

Member of the management boardAnthony Jason Merriman

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
Andre Ganem	Member of the management board
Anthony Jason Merriman	Member of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

2,329,277

Net Profit (zł)

2,329,277

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
24,761,214
2,019,262
1,466,654
0.15
4.27
5.92
4,425,909
1,168,077
0
1,070,760

2023
30,221,528
2,541,245
2,053,424
0.18
4.91
6.79
6,516,165
1,358,509
0
2,135,800

2024
40,374,013
3,310,379
2,329,277
0.20
5.41
5.77
8,845,442
1,791,541
0
2,280,263

2024
40,374,013
3,310,379
2,329,277
0.20
5.41
5.77
8,845,442
1,791,541
0
2,280,263

Turnover (zł)

2024

Turnover (zł)

40,374,013 zł34 % *

Profit before tax (zł)

3,310,379 zł30 % *

Net Profit (zł)

2,329,277 zł13 % *

Working capital requirement (%)

0.20 11.11 % *

Liquidity ratio

5.41 10.18 % *

Net profitability (%)

5.77 %-15.02 % *

Equity (zł)

8,845,442 zł36 % *

Current liabilities (zł)

1,791,541 zł32 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

2,280,263 zł7 % *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

WORLDWIDE CLINICAL TRIALS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
16/07/2025	OD 01.01.2024 DO 31.12.2024
13/09/2024	OD 01.01.2023 DO 31.12.2023
28/07/2023	OD 01.01.2022 DO 31.12.2022
02/11/2022	OD 01.01.2018 DO 31.12.2018
02/11/2022	OD 01.01.2019 DO 31.12.2019